Diaceutics Balance Sheet

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	7.34	12.74	16.67	19.84	19.68
Cash & Short-Term Investments	7.34	12.74	16.67	19.84	19.68
Cash Growth	-42.37%	-23.54%	-16.00%	0.84%	-22.10%
Accounts Receivable	21.26	14.81	9.83	8.37	7
Other Receivables	0.76	0.89	0.3	2.05	2.92
Receivables	22.02	15.7	10.13	10.43	9.92
Prepaid Expenses	-	1.08	1.24	0.63	0.43
Other Current Assets	-	-	-	-	0.04
Total Current Assets	29.36	29.53	28.04	30.9	30.06
Property, Plant & Equipment	1.66	1.68	1.9	2.09	2.13
Other Intangible Assets	16.08	15.41	15.26	15.04	12.61
Long-Term Deferred Tax Assets	2.9	2	1.14	0.05	0
Long-Term Deferred Charges	-	-	-	0.18	0.22
Total Assets	50.01	48.62	46.34	48.26	45.01
Accounts Payable	8.25	1.22	1.07	0.76	0.51
Accrued Expenses	-	5.05	2.26	2	1.31
Short-Term Debt	-	-	-	-	0.13
Current Portion of Leases	0.27	0.15	0.15	0.12	0.15
Current Income Taxes Payable	0.03	0.47	0.47	0.42	0.33
Current Unearned Revenue	-	0.34	0.41	0.41	0.21
Other Current Liabilities	-	0.54	0.04	0.04	-
Total Current Liabilities	8.55	7.77	4.38	3.75	2.63
Long-Term Leases	0.88	0.91	1.06	1.21	1.29
Long-Term Deferred Tax Liabilities	-	-	0.03	0.71	0.45
Other Long-Term Liabilities	0.1	0.09	0.09	0.08	-
Total Liabilities	9.53	8.76	5.56	5.74	4.36
Common Stock	0.17	0.17	0.17	0.17	0.17
Additional Paid-In Capital	-	-	37.13	37.13	36.86
Retained Earnings	41.6	40.63	4.04	5.34	4.08
Treasury Stock	-0.31	-0.31	-0.31	-0.26	-0.17
Comprehensive Income & Other	-0.98	-0.63	-0.24	0.14	-0.3
Shareholders' Equity	40.48	39.86	40.79	42.51	40.65
Total Liabilities & Equity	50.01	48.62	46.34	48.26	45.01
Total Debt	1.15	1.06	1.21	1.33	1.56
Net Cash (Debt)	6.19	11.68	15.46	18.51	18.11
Net Cash Growth	-47.00%	-24.43%	-16.48%	2.20%	-27.94%
Net Cash Per Share	0.07	0.14	0.18	0.22	0.21
Filing Date Shares Outstanding	91.82	84.52	84.25	84.26	83.94
Total Common Shares Outstanding	91.82	84.52	84.25	84.26	83.94
Working Capital	20.81	21.76	23.66	27.14	27.43
Book Value Per Share	0.44	0.47	0.48	0.50	0.48
Tangible Book Value	24.4	24.44	25.52	27.47	28.04
Tangible Book Value Per Share	0.27	0.29	0.30	0.33	0.33
Machinery	-	0.83	0.73	0.62	0.48
Leasehold Improvements	-	0.53	0.53	0.53	0.48
Order Backlog	-	24.93	26.52	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.